131 related articles for article (PubMed ID: 1467173)
1. Alveolar rhabdomyosarcoma in a child with diffuse bone marrow involvement and chromosomal translocation (2;13).
Olgun N; Irken G; Oren H; Oren B; Altungöz O; Ozen E; Sakizli M; Cevik N
Pediatr Hematol Oncol; 1992; 9(4):385-7. PubMed ID: 1467173
[No Abstract] [Full Text] [Related]
2. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Thomson B; Hawkins D; Felgenhauer J; Radich J
Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
[TBL] [Abstract][Full Text] [Related]
3. A disseminated alveolar rhabdomyosarcoma in a 9-year-old boy disclosed by chromosomal translocation (2;13) (q35;q14).
Brichard B; Ninane J; Gosseye S; Verellen-Dumoulin C; Vermylen C; Rodhain J; Cornu G
Pediatr Hematol Oncol; 1991; 8(3):215-9. PubMed ID: 1742179
[TBL] [Abstract][Full Text] [Related]
4. [Alveolar rhabdomyosarcoma with massive bone marrow involvement and 2;13 chromosome translocation].
Naito H; de Higa EH; Kobayashi R; Shikano T; Ishikawa Y; Nojima T
Rinsho Ketsueki; 1992 Feb; 33(2):238-43. PubMed ID: 1635176
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyosarcoma presenting as acute leukemia.
Morandi S; Manna A; Sabattini E; Porcellini A
J Pediatr Hematol Oncol; 1996 Aug; 18(3):305-7. PubMed ID: 8689348
[TBL] [Abstract][Full Text] [Related]
6. Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations.
Douglass EC; Shapiro DN; Valentine M; Rowe ST; Carroll AJ; Raney RB; Ragab AH; Abella SM; Parham DM
Med Pediatr Oncol; 1993; 21(2):83-7. PubMed ID: 8433683
[TBL] [Abstract][Full Text] [Related]
7. A specific chromosomal abnormality in rhabdomyosarcoma.
Douglass EC; Valentine M; Etcubanas E; Parham D; Webber BL; Houghton PJ; Houghton JA; Green AA
Cytogenet Cell Genet; 1987; 45(3-4):148-55. PubMed ID: 3691179
[TBL] [Abstract][Full Text] [Related]
8. Chromosome translocation (2;13)(q37;q14) in a disseminated alveolar rhabdomyosarcoma.
Engel R; Ritterbach J; Schwabe D; Lampert F
Eur J Pediatr; 1988 Oct; 148(1):69-71. PubMed ID: 3197735
[TBL] [Abstract][Full Text] [Related]
9. Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma.
Salles MT; Neyra O; Taja L; Cervantes G; Gagnière M; Cerrillo M; Mohar A; Osornio A; Reynoso E; Gorodezky G
Cancer Genet Cytogenet; 1992 Mar; 59(1):80-3. PubMed ID: 1372839
[TBL] [Abstract][Full Text] [Related]
10. [Chromosomal translocation (2;13) in disseminated rhabdomyosarcoma].
Pérez-Vera P; Braun G; Rivera-Luna R; Cárdenas R; Carnevale A
Bol Med Hosp Infant Mex; 1992 May; 49(5):309-12. PubMed ID: 1605879
[TBL] [Abstract][Full Text] [Related]
11. Solid alveolar rhabdomyosarcoma with a t(2;13).
Yule SM; Bown N; Malcolm AJ; Reid MM; Pearson AD
Cancer Genet Cytogenet; 1995 Apr; 80(2):107-9. PubMed ID: 7736424
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. A report from the intergroup rhabdomyosarcoma study.
Ruymann FB; Newton WA; Ragab AH; Donaldson MH; Foulkes M
Cancer; 1984 Jan; 53(2):368-73. PubMed ID: 6546301
[TBL] [Abstract][Full Text] [Related]
13. Tandem triplication of the BCL2 gene in CD5-positive intravascular large B cell lymphoma with bone marrow involvement.
Yamamoto K; Okamura A; Yakushijin K; Hayashi Y; Matsuoka H; Minami H
Ann Hematol; 2014 Oct; 93(10):1791-3. PubMed ID: 24577512
[No Abstract] [Full Text] [Related]
14. The predictive value of initial cytostatic response in primary unresectable rhabdomyosarcoma in children.
Treuner J; Suder J; Keim M; Kaatsch P; Niethammer D
Acta Oncol; 1989; 28(1):67-72. PubMed ID: 2706134
[TBL] [Abstract][Full Text] [Related]
15. A variant (2;13) translocation in rhabdomyosarcoma.
Dal Cin P; Brock P; Aly MS; Casteels-Van Daele M; De Wever I; Van Damme B; Van den Berghe H
Cancer Genet Cytogenet; 1991 Sep; 55(2):191-5. PubMed ID: 1933821
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
[TBL] [Abstract][Full Text] [Related]
17. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA
J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200
[TBL] [Abstract][Full Text] [Related]
18. [Rhabdomyosarcoma--VAC regimen].
Cho Y
Nihon Rinsho; 2015 Feb; 73 Suppl 2():661-4. PubMed ID: 25831844
[No Abstract] [Full Text] [Related]
19. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
[TBL] [Abstract][Full Text] [Related]
20. Systemic rhabdomyosarcoma with diffuse bone marrow involvement. Case report of an unusual presentation.
Almanaseer IY; Trujillo YP; Taxy JB; Okuno T
Am J Clin Pathol; 1984 Sep; 82(3):349-53. PubMed ID: 6465102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
